“The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID : VEN/AZA effectively targets AML clones”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022041, Apr. 2022, doi: 10.4084/MJHID.2022.041.